Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders
Review
[키워드] adipocyte
adipose
Bone marrow
CD105
CD14
CD34
CD45
CD73
Cell
cell type
chemokines
chondrocyte
conditions
Coronavirus disease 2019 (COVID-19)
COVID-19
criteria
Crohn’s disease
Culture
Cytokines
disease
disorder
disorders
effective
eligible
evaluated
exceptional
expression
feature
global scientific community
Graft versus host diseases (GVHD)
GVHD
HLA-DR
homing
Host
identify
Immune cell
Immune-mediated
immunomodulatory
in vitro
Infectious disease
infiltration
Inflammatory response
involved
ISCT
lack
leucocyte
Mesenchymal stem/stromal cells (MSCs)
Migration
modulate
molecular mechanism
MSC
MSCs
multiple sclerosis
Multiple sclerosis (MS)
novel coronavirus disease
Osteoarthritis
Osteoarthritis (OA)
over
pathway
Patient
plasticity
recent finding
regulated
released
required
Secretome
signaling molecule
Society
Source
suggested
synergy
target cell
therapeutic
Therapeutic molecule
therapeutic option
tissue
Treatment
umbilical
[DOI] 10.1186/s13287-021-02265-1 PMC 바로가기 [Article Type] Review
[DOI] 10.1186/s13287-021-02265-1 PMC 바로가기 [Article Type] Review